• Featured abstract: New treatment option for prostate cancer Transurethral ultrasound ablation is a promising treatment for prostate cancer, with better outcomes and fewer side effects than traditional treatment.
bit.ly/3Qffw9r
• Featured abstract: Registry demonstrates safe and effective removal of acute, subacute and chronic thrombus Recent outcomes from the ongoing, real-world CLOUT registry demonstrate that the ClotTriever System safely and effectively removes acute, subacute and chronic thrombus, according to data detailed in “Safety and effectiveness of the ClotTriever system for treating deep vein thrombosis of all chronicities: CLOUT registry six-month outcomes.”
bit.ly/3QeIeaM
• Featured abstract: Improving anti- HCC immune response Using a matrix metalloproteinase (MMP) inhibitor with cryoablation to treat hepatocellular carcinoma (HCC) improved CD8 T-cell immune response in a mice model, according to researchers.
bit.ly/3MF23oG
• Featured abstract preview: Height restoration Three different procedures were shown to demonstrate equivalent height restoration in patients with vertebral compression fractures, and one procedure in particular may exhibit less height loss in highly physical patients, according to a new study.
bit.ly/3tn906Z
• Featured abstract: AI as a predictor of TACE success A machine learning program at Penn State Heart and Vascular Institute was able to predict the response of hepatocellular carcinoma (HCC) to transarterial chemoembolization (TACE) in about 80% of the cases. However, the program performed even better when predicting long-term response.
bit.ly/3awIsti
Abstracts of the year:
• Y-90 radioembolization of colorectal cancer metastatic to the liver Yttrium-90 (Y-90) microsphere embolization, when deployed as part of second-line therapy, contributed to overall survival in patients with colorectal liver metastases, according to data from the RESiN registry.
bit.ly/3aS5Ph3
• Y-90 as first-line treatment for intrahepatic cholangiocarcinoma Radioembolization can be considered as first-line treatment for unresectable intrahepatic cholangiocarcinoma (ICH).
bit.ly/3zCdIl8
• Breast cancer liver metastasis Physicians may be able to identify several new biomarkers related to immune activation to aid in patient selection for radioembolization of breast cancer liver metastasis, according to data in “Immune activation markers and response to radioembolization of breast cancer liver metastasis: Pilot study.”
bit.ly/3O9dMgj
• Potential new IR treatment for lumbar disc herniations Interventional radiologists may provide a more effective and minimally invasive treatment for lumbar disc herniations typically treated by open surgery, according to data from a recent European multicenter pilot trial.
bit.ly/3NPG2EY
sirweb.org/irq | 17
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
